Archive

Telix submits European marketing authorisation application for prostate cancer imaging product
Pressrelease from Telix Pharmaceutical. Melbourne (Australia) …
Pressrelease from Telix Pharmaceutical. Melbourne (Australia) and Liège (Belgium) – 1st May 2020. Telix Pharmaceuticals Limited (ASX: TLX ‘Telix’ the ‘Company’) today announces that it…
Read more